Fibroadenolipoma
WikiDoc Resources for Fibroadenolipoma |
Articles |
---|
Most recent articles on Fibroadenolipoma Most cited articles on Fibroadenolipoma |
Media |
Powerpoint slides on Fibroadenolipoma |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Fibroadenolipoma at Clinical Trials.gov Trial results on Fibroadenolipoma Clinical Trials on Fibroadenolipoma at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Fibroadenolipoma NICE Guidance on Fibroadenolipoma
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Fibroadenolipoma Discussion groups on Fibroadenolipoma Patient Handouts on Fibroadenolipoma Directions to Hospitals Treating Fibroadenolipoma Risk calculators and risk factors for Fibroadenolipoma
|
Healthcare Provider Resources |
Causes & Risk Factors for Fibroadenolipoma |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Hamartoma of the breast; breast with in a breast
Overview
Fibroadenolipoma is the benign proliferation of fibrous, glandular, and fatty tissue surrounded by a thin capsule of connective tissue. Majority of these lesions occur in women over 35 years of age. When the lesion is asymptomatic and demonstrates a typical mammographic appearance, the patient can be followed up mammographically without the need for ultrasound or intervention.
Diagnosis
- At mammography, fibroadenolipoma are typically well-circumscribed, round to oval masses containing both fat and soft-tissue density with a thin, radiopaque pseudocapsule.
- At ultrasound, a sharply defined, heterogeneous oval mass is seen, or the lesion may manifest as normal glandular tissue.